Share
Journal Information
Last published articles
Original Article
Enteral versus intravenous antibiotics for critically ill patients: A pilot studyDayana dos Santos Oliveira, Julia Vitória da Rocha, Juliano Gasparetto, Carolina Hikari Yamada, Joao Paulo Telles, Felipe Francisco Tuon
Full text access
Original Article
Economic evaluation of ceftazidime-avibactam vs. polymyxin B for treatment of hospital-acquired and ventilator-associated bacterial pneumoniaJessica Matuoka, Daniela Vianna Pachito, Filipe Piastrelli, Lorena Cristina Correa Fehlberg, Haliton Alves de Oliveira Junior
Full text access
Original Article
RIMOXCLAMIN: New therapeutic regimen for Hansen’s Disease cure based on effective sensitivity recoveryMarco Andrey Cipriani Frade, Gustavo Sartori Albertino, Filipe Rocha Lima, Natália Aparecida de Paula, Fabiana Aparecida Correa Cinto, Fernanda Cruz Perecin, Andrezza Westin, Wilson Marques Junior, Helena Barbosa Lugão
Full text access
Original Article
COVID-19 hospitalization in vaccinated and non-vaccinated patients: Clinical profile and outcomesLaura Holtman-Ferreira, Elessandra de Souza Bitencourt, Betina Mendez de Alcantara Gabardo, Susanne Edinger Pereira, Francine Teixeira, Diego da Silva Magatão, Vitor Loureiro Dias, Ricardo Petterle, ... Sonia Mara Raboni
Braz J Infect Dis. 2025;29:104537
Full text access
Case Report
Disseminated bartonellosis and EBV reactivation in an adolescent treated with upadacitinibVincent Pargny, Emilie Delugre, Raphael Janela, Soumaya Skalli, Abdeljalil Zeggay, Hortense Petat
Braz J Infect Dis. 2025;29:104536
Highlights
- •
Bartonella henselae can cause severe infections in immunocompromised patients.
- •
Bartonella henselae infection should be suspected in cases of fever of unknown origin.
- •
Upadacitinib (JAK inhibitor) increases the risk of severe bacterial infections, opportunistic infections and viral reactivation.
- •
Upadacitinib increases the risk of CPK elevation.
Full text access
Brief Communications
Real-world accuracy of SARS-CoV-2 antigen detection compared with qPCR: A cross-sectional study in Toledo - PR, BrazilCarla Adriane Royer, Regis Goulart Rosa, Maicon Falavigna, Jaqueline Carvalho de Oliveira
Braz J Infect Dis. 2025;29:104520
Full text access
Brief Communication
Increased rates of blaNDM in Pseudomonas aeruginosa in a tertiary care hospital in southern BrazilPatricia Orlandi Barth, Dariane Castro Pereira, Camila Mörschbächer Wilhelm, Kellen Figueira Tragnago, Afonso Luís Barth
Braz J Infect Dis. 2025;29:104523
Full text access
Brief Communication
Tuberculosis parenteral therapeutic regimens for critical patients or non-functional intestinal tract: Brief review and proposal of protocolAntonio Camargo Martins, Márcia Teixeira Garcia, Mariângela Ribeiro Resende
Braz J Infect Dis. 2025;29:104526
Full text access
Publish in
The Brazilian Journal of Infectious Diseases
